美国FDA生物制品紫皮书数据库（U.S. FDA Purple Book: Database of Licensed Biological Products）- 药物在线

商品名	申请号	产品号	BLA类型	非专利名称	剂型	给药途径	规格/剂量	产品形式	批准日期	申请人	市场状态	许可证状态	参考产品非专利名称	参考产品专利名称
Tepezza	761143	001	351(a)	teprotumumab-trbw	For Injection	Intravenous	500MG	Single-Dose Vial	2020/01/21	Horizon Therapeutics Ireland DAC	Rx	Licensed
Enhertu	761139	001	351(a)	fam-trastuzumab deruxtecan-nxki	For Injection	Intravenous	100MG	Single-Dose Vial	2019/12/20	Daiichi Sankyo, Inc	Rx	Licensed
Ervebo	125690	001	351(a)	Ebola Zaire Vaccine, Live	Injection	Intramuscular	1ML	Single-Dose Vial	2019/12/19	Merck Sharp & Dohme LLC	Rx	Licensed
Padcev	761137	001	351(a)	enfortumab vedotin-ejfv	For Injection	Intravenous	20MG	Single-Dose Vial	2019/12/18	Astellas Pharma US, Inc.	Rx	Licensed
Padcev	761137	002	351(a)	enfortumab vedotin-ejfv	For Injection	Intravenous	30MG	Single-Dose Vial	2019/12/18	Astellas Pharma US, Inc.	Rx	Licensed
Avsola	761086	001	351(k) Biosimilar	infliximab-axxq	For Injection	Intravenous	100MG	Single-Dose Vial	2019/12/06	Amgen Inc.	Rx	Licensed	infliximab	Remicade
Abrilada	761118	001	351(k) Interchangeable	adalimumab-afzb	Injection	Subcutaneous	40MG/0.8ML	Autoinjector	2019/11/15	Pfizer Inc.	Rx	Licensed	adalimumab	Humira
Abrilada	761118	002	351(k) Interchangeable	adalimumab-afzb	Injection	Subcutaneous	40MG/0.8ML	Pre-Filled Syringe	2019/11/15	Pfizer Inc.	Rx	Licensed	adalimumab	Humira
Abrilada	761118	003	351(k) Interchangeable	adalimumab-afzb	Injection	Subcutaneous	20MG/0.4ML	Pre-Filled Syringe	2019/11/15	Pfizer Inc.	Rx	Licensed	adalimumab	Humira
Abrilada	761118	004	351(k) Interchangeable	adalimumab-afzb	Injection	Subcutaneous	10MG/0.2ML	Pre-Filled Syringe	2019/11/15	Pfizer Inc.	Disc	Licensed	adalimumab	Humira
Abrilada	761118	005	351(k) Interchangeable	adalimumab-afzb	Injection	Subcutaneous	40MG/0.8ML	Single-Dose Vial	2019/11/15	Pfizer Inc.	Rx	Licensed	adalimumab	Humira
Adakveo	761128	001	351(a)	crizanlizumab-tmca	Injection	Intravenous	100MG/10ML (10MG/ML)	Single-Dose Vial	2019/11/15	Novartis Pharmaceuticals Corporation	Rx	Licensed
Basaglar	205692	002	351(a)	insulin glargine	Injection	Subcutaneous	300UNITS/3ML (100UNITS/ML)	Autoinjector	2019/11/15	Eli Lilly and Company	Rx	Licensed
Humalog	020563	005	351(a)	insulin lispro	Injection	Subcutaneous	300UNITS/3ML (100UNITS/ML)	Autoinjector	2019/11/15	Eli Lilly and Company	Rx	Licensed
Reblozyl	761136	001	351(a)	luspatercept-aamt	For Injection	Subcutaneous	25MG/VIAL	Single-Dose Vial	2019/11/08	Celgene Corporation, a Bristol-Myers Squibb Company	Rx	Licensed
Reblozyl	761136	002	351(a)	luspatercept-aamt	For Injection	Subcutaneous	75MG/VIAL	Single-Dose Vial	2019/11/08	Celgene Corporation, a Bristol-Myers Squibb Company	Rx	Licensed
Bayrab,Hyperrab	101144	003	351(a)	Rabies Immune Globulin (Human)	Injection	Intramuscular	900 IU/ 3ML	Single-Dose Vial	2019/11/06	Grifols Therapeutics LLC	Rx	Licensed
Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent	103914	009	351(a)	Influenza Virus Vaccine	Injection	Intramuscular	240UG/.7ML	Pre-Filled Syringe	2019/11/04	Sanofi Pasteur Inc.	Rx	Licensed
Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent	103914	010	351(a)	Influenza Virus Vaccine	Injection	Intramuscular	45UG/.5ML	Multi-Dose Vial	2019/11/04	Sanofi Pasteur Inc.	Rx	Licensed
Ziextenzo	761045	001	351(k) Biosimilar	pegfilgrastim-bmez	Injection	Subcutaneous	6MG/0.6ML	Pre-Filled Syringe	2019/11/04	Sandoz Inc.	Rx	Licensed	pegfilgrastim	Neulasta

药品商品名或专利药名Proprietary (Brand) Name
药品通用名或非专利名称Nonproprietary (Proper) Name
药品申请号BLA Number
产品号Product Number
剂型Dosage Form
给药途径Route of Administration
产品形式Product Presentation
药品规格或剂量Strength
药品注册申请人Applicant
参考产品非专利名称Reference Product Proper Name
参考产品专利名称Reference Product Proprietary Name
BLA类型License Type
药品的市场状态Marketing Status
许可证号License Number
许可证状态Licensure
产品批准日期Approval Date	-